Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 17Leukemia, Lymphocytic, Chronic, B-Cell 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Hodgkin Disease 15Multiple Myeloma 12Lymphoma, Non-Hodgkin 11Myelodysplastic Syndromes 10Lymphoma, Mantle-Cell 10Myeloproliferative Disorders 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Myeloid, Chronic-Phase 9Waldenstrom Macroglobulinemia 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Prolymphocytic 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Anemia, Refractory, with Excess of Blasts 6Leukemia 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma 4Leukemia, Prolymphocytic, T-Cell 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Congenital Abnormalities 4Blast Crisis 4

Interventions

Tacrolimus 1Phlebotomy 1Cyclosporins 1Cyclosporine 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thymic aplasia × Cyclosporins × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡